Mediclinic International PLC (LON:MDC) had its price target cut by Citigroup Inc. from GBX 790 ($10.39) to GBX 720 ($9.47) in a research report released on Wednesday, October 18th. They currently have a neutral rating on the stock.
Several other research firms have also weighed in on MDC. Jefferies Group LLC reduced their target price on shares of Mediclinic International PLC from GBX 650 ($8.55) to GBX 550 ($7.23) and set an underperform rating on the stock in a report on Monday, September 25th. Credit Suisse Group restated a neutral rating on shares of Mediclinic International PLC in a report on Friday, July 21st. Morgan Stanley lowered shares of Mediclinic International PLC to an equal weight rating and reduced their target price for the company from GBX 825 ($10.85) to GBX 775 ($10.19) in a report on Thursday, June 29th. Finally, Investec lowered shares of Mediclinic International PLC to a hold rating and set a GBX 775 ($10.19) target price on the stock. in a report on Monday, June 26th. Two research analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of GBX 665.33 ($8.75).
Shares of Mediclinic International PLC (LON:MDC) traded up GBX 6 ($0.08) during midday trading on Wednesday, hitting GBX 601 ($7.90). 1,207,591 shares of the stock traded hands, compared to its average volume of 1,690,000. Mediclinic International PLC has a one year low of GBX 577 ($7.59) and a one year high of GBX 941.50 ($12.38).
COPYRIGHT VIOLATION NOTICE: This news story was originally published by BBNS and is owned by of BBNS. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://baseballnewssource.com/markets/mediclinic-international-plc-mdc-given-new-gbx-720-price-target-at-citigroup-inc/1722497.html.
Mediclinic International PLC Company Profile
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with our FREE daily email newsletter.